WILLIAM WONG to Ribavirin
This is a "connection" page, showing publications WILLIAM WONG has written about Ribavirin.
Connection Strength
0.281
-
Cost-effectiveness analysis of sofosbuvir and velpatasvir in chronic hepatitis C patients with decompensated cirrhosis. J Viral Hepat. 2021 02; 28(2):260-267.
Score: 0.168
-
Cost-effectiveness of screening for hepatitis C in Canada. CMAJ. 2015 Feb 17; 187(3):E110-E121.
Score: 0.112